Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial

This publication has 24 references indexed in Scilit:

• SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group.
  BMJ, 1991
• Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1990
• Reinfarction after thrombölytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smoking
  Journal of the American College of Cardiology, 1990
• Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study
  The Lancet, 1990
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• Prognostic significance of angina pectoris before first acute myocardial infarction
  The American Journal of Cardiology, 1988
• THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
  The Lancet, 1988
• Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction
  Journal of the American College of Cardiology, 1986
• Recurrent myocardial infarction: clinical predictors and prognostic implications.
  Circulation, 1982
• Angina Pectoris Before and After Myocardial Infarction
  Chest, 1982